Suppr超能文献

Plasma concentrations of nortriptyline and its 10-hydroxy metabolite in depressed patients--relationship to the debrisoquine hydroxylation metabolic ratio.

作者信息

Nordin C, Siwers B, Benitez J, Bertilsson L

出版信息

Br J Clin Pharmacol. 1985 Jun;19(6):832-5. doi: 10.1111/j.1365-2125.1985.tb02723.x.

Abstract

In 20 depressed patients treated with nortriptyline (NT) there was a significant relationship between the plasma concentration of NT and the debrisoquine metabolic ratio (rs = 0.77; P less than 0.01). (The debrisoquine test was performed after stopping NT treatment). This is in agreement with the hypothesis that the hydroxylations of NT and debrisoquine are mediated by similar enzymatic mechanisms. In contrast there was no significant relationship between the debrisoquine metabolic ratio and the plasma concentrations of the active metabolite 10-hydroxy-nortriptyline. In 11 of the patients the debrisoquine metabolic ratio was significantly higher during than after NT treatment. This may be due to an inhibition of the debrisoquine hydroxylation by NT.

摘要

相似文献

2
Nortriptyline and debrisoquine hydroxylations in Ghanaian and Swedish subjects.
Clin Pharmacol Ther. 1984 Sep;36(3):374-8. doi: 10.1038/clpt.1984.190.
4
E- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylation.
Clin Pharmacol Ther. 1981 Aug;30(2):189-93. doi: 10.1038/clpt.1981.147.
8
Correlation between nortriptyline and debrisoquine hydroxylation in the human liver.
Life Sci. 1983 Aug 15;33(7):631-6. doi: 10.1016/0024-3205(83)90251-5.
9
Amitriptyline metabolism: relationship to polymorphic debrisoquine hydroxylation.
Clin Pharmacol Ther. 1983 Oct;34(4):516-20. doi: 10.1038/clpt.1983.207.

引用本文的文献

1
The Role of Metabolites of Antidepressants in the Treatment of Depression.
CNS Drugs. 1997 Apr;7(4):273-312. doi: 10.2165/00023210-199707040-00003.
2
Pharmacogenetics and gender association with psychotic episodes on nortriptyline lower doses: patient cases.
ISRN Pharm. 2011;2011:805983. doi: 10.5402/2011/805983. Epub 2011 Jul 20.
3
The CYP2D6 polymorphism in relation to the metabolism of amitriptyline and nortriptyline in the Faroese population.
Br J Clin Pharmacol. 2008 Jan;65(1):134-8. doi: 10.1111/j.1365-2125.2007.02969.x. Epub 2007 Aug 31.
4
The impact of the CYP2D6-polymorphism on dose recommendations for current antidepressants.
Eur Arch Psychiatry Clin Neurosci. 2006 Aug;256(5):287-93. doi: 10.1007/s00406-006-0663-5.
5
Quantitative pharmacogenetics of nortriptyline: a novel approach.
Clin Pharmacokinet. 2001;40(11):869-77. doi: 10.2165/00003088-200140110-00005.
6
Metabolism of tricyclic antidepressants.
Cell Mol Neurobiol. 1999 Jun;19(3):373-409. doi: 10.1023/a:1006949816036.
7
Tolterodine does not affect the human in vivo metabolism of the probe drugs caffeine, debrisoquine and omeprazole.
Br J Clin Pharmacol. 1999 Feb;47(2):145-50. doi: 10.1046/j.1365-2125.1999.00865.x.
9
Steady-state plasma levels of nortriptyline and its 10-hydroxy metabolite: relationship to the CYP2D6 genotype.
Psychopharmacology (Berl). 1996 Feb;123(4):315-9. doi: 10.1007/BF02246640.
10
Pharmacokinetic optimisation of tricyclic antidepressant therapy.
Clin Pharmacokinet. 1993 Apr;24(4):301-18. doi: 10.2165/00003088-199324040-00004.

本文引用的文献

1
Accumulation of debrisoquine by platelets in vivo: a model of events at the peripheral adrenergic neurone.
Br J Clin Pharmacol. 1980 Apr;9(4):419-25. doi: 10.1111/j.1365-2125.1980.tb01071.x.
2
E- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylation.
Clin Pharmacol Ther. 1981 Aug;30(2):189-93. doi: 10.1038/clpt.1981.147.
3
Nortriptyline metabolism in chronic renal failure: metabolite elimination.
Clin Pharmacol Ther. 1982 Sep;32(3):322-9. doi: 10.1038/clpt.1982.167.
4
Genetically determined oxidation capacity and the disposition of debrisoquine.
Br J Clin Pharmacol. 1983 Apr;15(4):443-50. doi: 10.1111/j.1365-2125.1983.tb01528.x.
5
The debrisoquine hydroxylation test predicts steady-state plasma levels of desipramine.
Br J Clin Pharmacol. 1983 Mar;15(3):388-90. doi: 10.1111/j.1365-2125.1983.tb01518.x.
6
Weak binding of 10-hydroxymetabolites of nortriptyline to rat brain muscarinic acetylcholine receptors.
Life Sci. 1984 Sep 24;35(13):1379-83. doi: 10.1016/0024-3205(84)90395-3.
7
Nortriptyline and debrisoquine hydroxylations in Ghanaian and Swedish subjects.
Clin Pharmacol Ther. 1984 Sep;36(3):374-8. doi: 10.1038/clpt.1984.190.
8
Correlation between nortriptyline and debrisoquine hydroxylation in the human liver.
Life Sci. 1983 Aug 15;33(7):631-6. doi: 10.1016/0024-3205(83)90251-5.
10
Pronounced inhibition of noradrenaline uptake by 10-hydroxymetabolites of nortriptyline.
Life Sci. 1979 Oct 8;25(15):1285-92. doi: 10.1016/0024-3205(79)90393-x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验